Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk Stratification on Pheochromocytoma and Paraganglioma from Laboratory and Clinical Medicine

27 Aug 2018

Abstract excerpt

Pheochromocytoma (PCC) and sympathetic paraganglioma (PGL) are rare neuroendocrine tumors characterized by catecholamine production in the adrenal medulla and extra-adrenal paraganglia. PCC and PGL (PPGL) with metastasis was termed malignant PPGL. However, the distinction between “benign” and “malignant” PPGLs has been debated. Currently, all PPGLs are believed to have some metastatic potential and are assigned...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal and Paraganglionic Tumors
Share to Cancer, Hypoxia, and Metabolism
Share to Hormonal Regulation and Hypertension

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30150569
DOI: 10.3390/jcm7090242

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk Stratification on Pheochromocytoma and Paraganglioma from Laboratory and Clinical MedicinePMID 30150569Read ↗

Risk Stratification on Pheochromocytoma and Paraganglioma from Laboratory and Clinical MedicineSemantic proximity Read ↗

Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.Semantic proximity Read ↗

Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task ForceSemantic proximity Read ↗

Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision MedicineSemantic proximity Read ↗

Metastatic Pheochromocytoma and Paraganglioma: Clinicopathological Analysis of 35 CasesSemantic proximity Read ↗

Pheochromocytoma–Paraganglioma Syndrome: A Multiform Disease with Different Genotype and Phenotype FeaturesSemantic proximity Read ↗

Pheochromocytomas and Paragangliomas: From Genetic Diversity to Targeted TherapiesSemantic proximity Read ↗

Pheochromocytomas and Paragangliomas: New Developments with Regard to Classification, Genetics, and Cell of OriginSemantic proximity Read ↗

Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and ImagingSemantic proximity Read ↗

Clinical Syndromes and Genetic Screening Strategies of Pheochromocytoma and ParagangliomaSemantic proximity Read ↗

Perioperative Management of Pheochromocytomas and Sympathetic ParagangliomasSemantic proximity Read ↗

Pheochromocytoma and Paraganglioma: Genetics, Diagnosis, and Treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.